Merck & Co.

  • Merck reaches $950 million settlement over off-label marketing of Vioxx

    Pharmaceutical giant Merck & Co. agreed Tuesday to pay $950 million to settle criminal and civil charges surrounding the alleged false promotion of its painkiller Vioxx, which was withdrawn from the marketplace after claims of heart attacks and other injuries surfaced.

  • Several drug makers win in product liability litigation

    According to an analysis reported by Reuters, a series of wins for pharmaceutical companies defending themselves in product liability litigation may be good news for corporate defendants in general.

  • Under shareholder pressure, companies disclose political spending

    According to a recent survey by the Center for Political Accountability, a non-profit created in 2003 with a goal to bring transparency to corporations' political spending, an increasing number of companies is disclosing the contributions they make to political campaigns.

  • Merck wins its fourth Fosamax case

    Yesterday drug maker Merck & Co. won another case in which a patient claimed the company’s osteoporosis drug Fosamax caused jaw and dental injuries.

  • Walgreens names new GC

    There’s a changing of the counsel guard at Walgreens. Effective yesterday, Walgreens’ Executive Vice President, General Counsel and Corporate Secretary Dana Green officially retired after 37 years of leal service. The company hired Thomas Sabatino Jr. to take her place.

Advertisement. Closing in 15 seconds.